Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Centers for Disease Control and Prevention |
---|---|
Information provided by: | Centers for Disease Control and Prevention |
ClinicalTrials.gov Identifier: | NCT00164333 |
The purpose of the study is to test the efficacy of TAP, a behavioral intervention, in improving sexual safety and treatment adherence among gay and bisexual men infected with HIV. It is hypothesized that those who are in the intervention group will report reductions in unprotected sex with HIV-negative and unknown-status partners; and will show stricter adherence to their treatment regimens, compared to the individuals in the standard-of-care, control group.
Condition | Intervention | Phase |
---|---|---|
HIV |
Behavioral: TAP: Treatment Advocacy Program |
Phase II |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Open Label, Active Control, Factorial Assignment, Efficacy Study |
Official Title: | The Treatment Advocacy Program |
Estimated Enrollment: | 300 |
Study Start Date: | September 2004 |
Estimated Study Completion Date: | June 2006 |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Male |
Inclusion Criteria:
Exclusion Criteria:
United States, Illinois | |
Howard Brown Medical Center | |
Chicago, Illinois, United States, 60613 |
Principal Investigator: | Dogan Eroglu, PhD. | Centers for Disease Control and Prevention |
Study ID Numbers: | CDC-NCHSTP-3797, R 18/CCR520972-01 |
Study First Received: | September 9, 2005 |
Last Updated: | September 9, 2005 |
ClinicalTrials.gov Identifier: | NCT00164333 History of Changes |
Health Authority: | United States: Federal Government |
HIV Infections Acquired Immunodeficiency Syndrome |